These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14628585)

  • 1. [Use of enerion in psychovegetative syndrome with pronounced asthenia].
    Veĭn AM; Fedotova AV; Gordeev SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(10):36-9. PubMed ID: 14628585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychoneurophysiological assessment of recovery of cognitive function in patients with asthenia during rehabilitation.
    Gordeev SA; Fedotova AV; Vein AM
    Bull Exp Biol Med; 2003 Nov; 136(5):429-31. PubMed ID: 14968150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of enerion in the treatment of asthenic disorders in patients after mild cranio-cerebral trauma].
    Levin OS; Slizkova IuB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(5):44-8. PubMed ID: 18379496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the specific treatment of asthenic states: focus on sulbutiamine].
    Bykov YV; Bekker RA
    Ter Arkh; 2022 Jun; 94(5):689-694. PubMed ID: 36286970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of the drug enerion in the treatment of patients with psychogenic (functional) erectile dysfunction].
    Dmitriev DG; Gamidov SI; Permiakova OV
    Urologiia; 2005; (1):32-5. PubMed ID: 15776829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of bis-(isobutyryloxy-2-ethyl)-1-N-(amino-4-methyl-2-pyrimidyl-5) methyl formamido-2-propene-1-yl disulfide (Sulbutiamin) in neurasthenic and neuroastheniform syndromes].
    Balestreri R; Bertolini S; Barban G; Montanari D; Jacopino JE; Chiodini G; Reggiani E
    Arch Maragliano Patol Clin; 1979; 35():19-34. PubMed ID: 400511
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia.
    Shah SN;
    J Assoc Physicians India; 2003 Sep; 51():891-5. PubMed ID: 14710977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of asthenic syndrome in elderly people after acute respiratory viral infection].
    Poverennova IE; Zolotovskaia IA; Bezgina EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):73-6. PubMed ID: 25403306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy of the psychovegetative syndrome].
    Heuter H
    Ther Ggw; 1977 May; 116(5):946-66. PubMed ID: 867297
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychophysical asthenia and its management using phenylpyrrolidinyl pentane].
    Zoppi HA; Leira NI; Kaczmer O
    Prensa Med Argent; 1968 Oct; 55(33):1648-50. PubMed ID: 5714171
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-hemodynamic effects of psychotropic preparations and psychosomatic correlations in cardiac rhythm disorders].
    Petrova TR; Skibitskiĭ VV
    Ter Arkh; 1986; 58(11):97-101. PubMed ID: 2435014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten].
    Voznesenskaia TG; Fokina NM; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):17-26. PubMed ID: 21322821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychosomatic correlations in patients with neurocirculatory dystonia and effectiveness of their treatment with psychotropic drugs].
    Volkov VS; Lazarev VI; Vinogradov VF; Gerasimeni VV
    Ross Med Zh; 1992; (1):34-7. PubMed ID: 1611266
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of cytoflavin on symptoms of asthenia, emotional disorders and autonomic regulation in patients with organic asthenic disorder].
    Polunina AG; Osinovskaia NA; Gudkova AN; Gekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(2):28-33. PubMed ID: 24662341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of tanakan on psychophysiological status of patients with asthenic disorders].
    Neznamov GG; Teleshova ES; Siuniakov SA; Morozov IS; Davydova IA; Zhirnov EN
    Eksp Klin Farmakol; 2002; 65(1):19-23. PubMed ID: 12025777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacology in the medically ill. General principles.
    Rubey RN; Lydiard RB
    Adv Psychosom Med; 1994; 21():1-27. PubMed ID: 7801824
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current treatment options for autonomic, cognitive and emotional disorders in patients with asthenic syndrome treated with recognan (citicoline)].
    Nemkova SA; Semenov DV; Petrova EA; Savchenko DV; Zavadenko NN; Vozvyshaeva MY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):27-34. PubMed ID: 31464286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New therapeutic concepts in asthenia as applied to the rehabilitation of coronary patients].
    Danel JL; Cristol R; Sliosberg R
    Sem Hop Ther; 1974; 50(7-8):453-7. PubMed ID: 4614450
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychosomatic disorders: psychotropic medications.
    DiGiacomo JN; Rosen H
    Psychosomatics; 1979 Feb; 20(2):95-107. PubMed ID: 419276
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of Adamantilbromphenylamine on Parameters of Immunity and Symptoms of Asthenia in Patients with Non-Psychotic Mental Disorders].
    Vetlugina TP; Nikitina VB; Sergeeva SA; Axenov MM; Lobacheva OA; Savochkina DN; Epanchintseva EM; Bokhan NA
    Vestn Ross Akad Med Nauk; 2015; (4):468-74. PubMed ID: 26710531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.